BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29408768)

  • 1. Craniopharyngiomas: A systematic review and evaluation of the current intratumoral treatment landscape.
    Mrowczynski OD; Langan ST; Rizk EB
    Clin Neurol Neurosurg; 2018 Mar; 166():124-130. PubMed ID: 29408768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracystic bleomycin for cystic craniopharyngiomas in children.
    Zheng J; Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008890. PubMed ID: 25233847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracystic bleomycin for cystic craniopharyngiomas in children.
    Zhang S; Fang Y; Cai BW; Xu JG; You C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008890. PubMed ID: 27416004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracystic bleomycin for cystic craniopharyngiomas in children.
    Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
    Cochrane Database Syst Rev; 2012 Apr; (4):CD008890. PubMed ID: 22513968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon.
    Dastoli PA; Nicácio JM; Silva NS; Capellano AM; Toledo SR; Ierardi D; Cavalheiro S
    Arq Neuropsiquiatr; 2011 Feb; 69(1):50-5. PubMed ID: 21359423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracystic treatments for craniopharyngioma.
    Steinbok P; Hukin J
    Neurosurg Focus; 2010 Apr; 28(4):E13. PubMed ID: 20367357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracystic interferon-α treatment leads to neurotoxicity in craniopharyngioma: case report.
    Sharma J; Bonfield CM; Singhal A; Hukin J; Steinbok P
    J Neurosurg Pediatr; 2015 Sep; 16(3):301-4. PubMed ID: 26023721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric craniopharyngioma: long-term results in 61 cases].
    Pancucci G; Massimi L; Caldarelli M; D'Angelo L; Sturiale C; Tamburrini G; Tufo T; Di Rocco C
    Minerva Pediatr; 2007 Jun; 59(3):219-31. PubMed ID: 17519867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases.
    Cavalheiro S; Di Rocco C; Valenzuela S; Dastoli PA; Tamburrini G; Massimi L; Nicacio JM; Faquini IV; Ierardi DF; Silva NS; Pettorini BL; Toledo SR
    Neurosurg Focus; 2010 Apr; 28(4):E12. PubMed ID: 20367356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review).
    Liu W; Fang Y; Cai B; Xu J; You C; Zhang H
    Neurosurgery; 2012 Nov; 71(5):909-15. PubMed ID: 22902333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.
    Hader WJ; Steinbok P; Hukin J; Fryer C
    Pediatr Neurosurg; 2000 Oct; 33(4):211-8. PubMed ID: 11124639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon-α-2b for children with recurrent craniopharyngioma.
    Yeung JT; Pollack IF; Panigrahy A; Jakacki RI
    J Neurosurg Pediatr; 2012 Dec; 10(6):498-503. PubMed ID: 23061825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does chemotherapy have a role in the management of craniopharyngioma?
    Hargrave DR
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():407-12. PubMed ID: 16700318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma.
    Cavalheiro S; Dastoli PA; Silva NS; Toledo S; Lederman H; da Silva MC
    Childs Nerv Syst; 2005 Aug; 21(8-9):719-24. PubMed ID: 16133276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
    Jakacki RI; Cohen BH; Jamison C; Mathews VP; Arenson E; Longee DC; Hilden J; Cornelius A; Needle M; Heilman D; Boaz JC; Luerssen TG
    J Neurosurg; 2000 Feb; 92(2):255-60. PubMed ID: 10659012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inflammation in the genesis of the cystic component of craniopharyngiomas.
    Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C
    Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report.
    Cavalheiro S; Sparapani FV; Franco JO; da Silva MC; Braga FM
    J Neurosurg; 1996 Jan; 84(1):124-6. PubMed ID: 8613819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma.
    Kim SD; Park JY; Park J; Lee JB; Kim SH; Lim DJ
    Clin Neurol Neurosurg; 2007 Apr; 109(3):236-41. PubMed ID: 17046151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment?
    Zanon N; Cavalheiro S; da Silva MC
    Surg Neurol; 2008 Jul; 70(1):66-9; discussion 69. PubMed ID: 18207525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.
    Agosti E; Zeppieri M; Antonietti S; Piazza A; Ius T; Fontanella MM; Fiorindi A; Panciani PP
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.